Rheumatoid Arthritis: Challenges, Innovations and Outcomes

Dear Colleagues,

Rheumatoid arthritis (RA) remains a prevalent autoimmune condition characterized by systemic inflammation and joint destruction, leading to significant morbidity and healthcare burden. The proposed Special Issue, titled "Rheumatoid Arthritis: Challenges, Innovations, and Outcomes", aims to encapsulate the current research landscape, identifying persistent challenges within diagnosis, treatment, and patient management. It seeks to highlight innovative approaches that promise to redefine clinical practices, from advancements in biotechnological treatments to novel therapeutic strategies and diagnostic tools.

This Special Issue will explore the multidisciplinary efforts underway to improve outcomes for RA patients, including the development of personalized medicine approaches, the integration of digital health technologies, and the evaluation of socio-economic factors affecting patient care. It invites contributions that address the core problems in RA management, such as early detection, prediction of treatment responses, and mitigation of long-term complications.

We aim to mobilize a global community of researchers, clinicians, and healthcare professionals to share their findings, insights, and experiences. By doing so, this Special Issue intends to foster a collaborative environment conducive to accelerating progress in combating RA; improving patient quality of life; and ultimately, achieving better health outcomes.

Dr. Marco Fornaro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• rheumatoid arthritis
• pathogenesis
• treatments
• outcomes
• autoimmunity